{"filing":{"accession_number":"0001185185-26-002468","cik":"0001864531","ticker":"VSEEW","company_name":"VSEE HEALTH, INC.","form":"8-K","filing_date":"2026-06-11","report_date":null,"primary_document":"vsee8k061026.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1864531/000118518526002468/vsee8k061026.htm"},"events":[{"id":5329,"run_id":4667,"accession_number":"0001185185-26-002468","anchor_item_number":"3.02","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.8,"summary":"VSee Health entered into a securities purchase agreement on June 8, 2026, issuing a secured promissory note for $271,739.13 principal at 18% annual interest due December 8, 2026, in an unregistered transaction exempt under Section 4(a)(2) of the Securities Act and/or Regulation D. The transaction represents a material financing arrangement with a security interest in company assets and mandatory repayment upon equity financing receipt, indicating significant financial stress.","company_name":"VSEE HEALTH, INC.","ticker":"VSEEW","filing_date":"2026-06-11","form":"8-K","submitted_at":null,"items":[{"id":6278,"accession_number":"0001185185-26-002468","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"VSee Health entered into a securities purchase agreement on June 8, 2026, issuing a secured promissory note for $271,739.13 principal with 18% annual interest due December 8, 2026. While this is a financing transaction rather than a traditional M\u0026A activity, it represents a material definitive agreement that materially affects the company's capital structure and financial obligations. The high interest rate, short maturity, security interest in company assets, and mandatory repayment upon equity financing receipt indicate significant financial stress and material impact on the registrant's financial position.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-11T20:12:45.419809+00:00","company_name":"","ticker":null,"filing_date":""},{"id":6279,"accession_number":"0001185185-26-002468","item_number":"2.03","item_title":"Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.45,"reasoning":"Item 2.03 discloses creation of a direct financial obligation by incorporating Item 1.01 by reference. Without access to Item 1.01's content, the specific nature of the obligation cannot be determined. Item 1.01 typically covers material acquisitions, dispositions, or business combinations (ma_activity), but could also involve debt issuance, asset sales, or other material transactions. Given the ambiguity and the materiality threshold of Item 2.03, this is classified as other_material pending review of the referenced Item 1.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-11T20:12:45.419809+00:00","company_name":"","ticker":null,"filing_date":""},{"id":6280,"accession_number":"0001185185-26-002468","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Item 3.02 discloses an unregistered sale of a Promissory Note in a transaction exempt under Section 4(a)(2) of the Securities Act and/or Regulation D. The filing references a Purchase Agreement and notes the issuance is exempt from registration, which is the hallmark of a private placement or PIPE transaction. This represents a dilutive equity issuance that would be material to investors assessing capital structure and ownership dilution.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-11T20:12:45.419809+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":6278,"accession_number":"0001185185-26-002468","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"VSee Health entered into a securities purchase agreement on June 8, 2026, issuing a secured promissory note for $271,739.13 principal with 18% annual interest due December 8, 2026. While this is a financing transaction rather than a traditional M\u0026A activity, it represents a material definitive agreement that materially affects the company's capital structure and financial obligations. The high interest rate, short maturity, security interest in company assets, and mandatory repayment upon equity financing receipt indicate significant financial stress and material impact on the registrant's financial position.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-11T20:12:45.419809+00:00","company_name":"VSEE HEALTH, INC.","ticker":"VSEEW","filing_date":"2026-06-11"},{"id":6279,"accession_number":"0001185185-26-002468","item_number":"2.03","item_title":"Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.45,"reasoning":"Item 2.03 discloses creation of a direct financial obligation by incorporating Item 1.01 by reference. Without access to Item 1.01's content, the specific nature of the obligation cannot be determined. Item 1.01 typically covers material acquisitions, dispositions, or business combinations (ma_activity), but could also involve debt issuance, asset sales, or other material transactions. Given the ambiguity and the materiality threshold of Item 2.03, this is classified as other_material pending review of the referenced Item 1.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-11T20:12:45.419809+00:00","company_name":"VSEE HEALTH, INC.","ticker":"VSEEW","filing_date":"2026-06-11"},{"id":6280,"accession_number":"0001185185-26-002468","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Item 3.02 discloses an unregistered sale of a Promissory Note in a transaction exempt under Section 4(a)(2) of the Securities Act and/or Regulation D. The filing references a Purchase Agreement and notes the issuance is exempt from registration, which is the hallmark of a private placement or PIPE transaction. This represents a dilutive equity issuance that would be material to investors assessing capital structure and ownership dilution.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-11T20:12:45.419809+00:00","company_name":"VSEE HEALTH, INC.","ticker":"VSEEW","filing_date":"2026-06-11"}]}